Jay Park

Equibles does not estimate personal net worth.

About Jay Park

Jay Park has spoken on 1 investor event across 1 company, most recently for Autolus Therapeutics plc on April 8, 2026. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 4 others.

Jay Park on recent calls

“So I think we're seeing slide five, and then I'll be going rather briefly and just highlighting and setting the stage for unmet needs in relapse refractory in adult patients with B-cell ALL.”

Other, VIRTUAL INVESTOR EVENT: SPOTLIGHT ON ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROGRAM · April 8, 2026

Affiliation history

Autolus Therapeutics plc (AUTL)
Transcript header (unverified)

Current

Company network

Autolus Therapeutics plc

AUTL

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-04-08

View calls and events

Leadership on record at Autolus Therapeutics plc

Michael W. Bonney Chairman, Board Member
Patrick McIlvenny Chief Accounting Officer
Rob Dolski Chief Accounting Officer
Elisabeth ("Lis") Leiderman, M.D. Board Member
Ravi M. Rao Board Member
Robert (“Bob”) W. Azelby Board Member
Ryan Richardson Board Member

Recent activity

Investor Update VIRTUAL INVESTOR EVENT: SPOTLIGHT ON ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROGRAM Autolus Therapeutics plc (AUTL)
2026-04-08